Zacks Research Upgrades Tenet Healthcare (NYSE:THC) to Strong-Buy

Tenet Healthcare (NYSE:THC) was upgraded by Zacks Research from a “hold” rating to a “strong-buy” rating in a note issued to investors on Tuesday,Zacks.com reports.

Several other research firms have also weighed in on THC. Mizuho set a $290.00 target price on Tenet Healthcare in a report on Monday. Cantor Fitzgerald reissued an “overweight” rating on shares of Tenet Healthcare in a report on Monday, July 27th. Robert W. Baird raised their price objective on Tenet Healthcare from $210.00 to $280.00 and gave the company a “neutral” rating in a research note on Tuesday, July 28th. Guggenheim upped their target price on Tenet Healthcare from $242.00 to $283.00 and gave the stock a “buy” rating in a research report on Tuesday, July 28th. Finally, Piper Sandler set a $308.00 price target on Tenet Healthcare in a report on Monday, July 27th. One analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $272.25.

Tenet Healthcare Price Performance

Shares of THC opened at $266.87 on Tuesday. The company has a debt-to-equity ratio of 2.00, a quick ratio of 1.35 and a current ratio of 1.41. The firm has a market cap of $21.49 billion, a PE ratio of 10.29, a PEG ratio of 0.99 and a beta of 1.23. Tenet Healthcare has a twelve month low of $157.58 and a twelve month high of $269.31. The firm’s 50 day moving average price is $205.96 and its 200 day moving average price is $202.93.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings results on Thursday, July 23rd. The company reported $6.12 EPS for the quarter, topping the consensus estimate of $4.26 by $1.86. Tenet Healthcare had a net margin of 10.27% and a return on equity of 26.76%. The company had revenue of $6.04 billion for the quarter, compared to analyst estimates of $5.43 billion. During the same quarter in the prior year, the business posted $4.02 EPS. Tenet Healthcare’s quarterly revenue was up 6.8% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. As a group, research analysts expect that Tenet Healthcare will post 21.07 EPS for the current fiscal year.

Insider Activity

In related news, EVP Lisa Y. Foo sold 10,000 shares of the stock in a transaction that occurred on Wednesday, July 29th. The stock was sold at an average price of $258.03, for a total transaction of $2,580,300.00. Following the completion of the sale, the executive vice president owned 32,053 shares in the company, valued at $8,270,635.59. This represents a 23.78% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Tammy Romo sold 2,500 shares of Tenet Healthcare stock in a transaction that occurred on Friday, August 7th. The stock was sold at an average price of $260.83, for a total value of $652,075.00. Following the completion of the transaction, the director directly owned 28,284 shares in the company, valued at approximately $7,377,315.72. This represents a 8.12% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 41,375 shares of company stock worth $9,793,347 over the last 90 days. Company insiders own 0.97% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the stock. PeakShares LLC lifted its stake in shares of Tenet Healthcare by 3.3% in the 1st quarter. PeakShares LLC now owns 1,693 shares of the company’s stock valued at $319,000 after acquiring an additional 54 shares during the last quarter. Sanctuary Advisors LLC increased its holdings in Tenet Healthcare by 0.5% in the 1st quarter. Sanctuary Advisors LLC now owns 11,900 shares of the company’s stock worth $2,246,000 after purchasing an additional 57 shares in the last quarter. Quadrant Capital Group LLC raised its position in Tenet Healthcare by 0.7% in the fourth quarter. Quadrant Capital Group LLC now owns 8,134 shares of the company’s stock valued at $1,616,000 after purchasing an additional 58 shares during the last quarter. Applied Finance Capital Management LLC boosted its stake in shares of Tenet Healthcare by 3.8% during the first quarter. Applied Finance Capital Management LLC now owns 1,644 shares of the company’s stock valued at $310,000 after purchasing an additional 60 shares in the last quarter. Finally, Syon Capital LLC increased its stake in shares of Tenet Healthcare by 5.3% in the fourth quarter. Syon Capital LLC now owns 1,254 shares of the company’s stock valued at $249,000 after buying an additional 63 shares during the period. Institutional investors own 95.44% of the company’s stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.